WHC is still in active development. Read this to understand our approach.
depiction of DNBPMBJFRRVTSJ-UHFFFAOYSA-N.svg
tripsit

5-meo-dipt

Check on tripsit

psychonaut

5-MeO-DiPT

Check on psychonaut

isomerdesign

5-MeO-DIPT

Check on isomerdesign

druglab

5-MeO-DiPT

Check on druglab

wiki

5-Methoxy-N,N-diisop...

Check on wiki

Data

InChI: InChI=1S/C17H26N2O/c1-12(2)19(13(3)4)9-8-14-11-18-17-7-6-15(20-5)10-16(14)17/h6-7,10-13,18H,8-9H2,1-5H3

Synonyms: BCP15442,5-Methoxy-N,N-diisopropyltryptamine,Indole, 3-[2-(diisopropylamino)ethyl]-5-methoxy,CHEMBL2140942,12D06G8W8E,Foxy methoxy,Tryptamine, N,N-diisopropyl-5-methoxy,N,N-Diisopropyl-5-methoxytryptamine,foxy,5meodipt,1H-Indole-3-ethanamine, 5-methoxy-N,N-bis(1-methylethyl)-,5-MeO-DIPT,N-isopropyl-N-(2-(5-methoxy-1H-indol-3-yl)ethyl)propan-2-amine,DB-049550,5-Methoxy-3-N,N-diisopropylaminoethylindole,CHEBI:48282,UNII-12D06G8W8E,PDSP1_000761,FOXY,DB01441,496D759,AM20120626,N-(1-methylethyl)-N-{2-[5-(methyloxy)-1H-indol-3-yl]ethyl}propan-2-amine,ACT09679,foxy-methoxy,5-Methoxy-N,N-Diisopropyltryptamine(5-MeO-DIPT),N-{2-[5-(methyloxy)-1H-indol-3-yl]ethyl}-N-(propan-2-yl)propan-2-amine,N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-propan-2-ylpropan-2-amine,Q2983762,Methoxy Foxy,4,4-DI-N-HEXYLOXYBIPHENYL,PDSP2_000749,5-Methoxy-N,N-Diisopropyltryptamine,AKOS015894311,FT-0630092,ZINC2583773,N-isopropyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propan-2-amine,3-(2-(DIISOPROPYLAMINO)ETHYL)-5-METHOXYINDOLE,3-[2-(Diisopropylamino)ethyl]-5-methoxyindole,DTXSID00193209,5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE [MI],SCHEMBL896818,NCGC00247717-01,4021-34-5,5-methoxy-N,N-bis(1-methylethyl)-1H-Indole-3-ethanamine,Di-iso-propyl[2-(5-methoxy-indol-3-yl)ethyl]azan,DEA No. 7439

Market name: 5-meo-dipt

Estimated data

Solubility: -2.861 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 88.2% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.